UEG - United European Gastroenterology

Session

Liver and Biliary III (Posters)

3-Mercaptopyruvate sulfurtransferase represses tumor progression and predicts prognosis in hepatocellular carcinoma

Meng Li, Qi Jin, Jie Zhang, Li Cen, Chaohui Yu, Youming Li

3-MERCAPTOPYRUVATE SULFURTRANSFERASE REPRESSES TUMOR PROGRESSION AND PREDICTS PROGNOSIS IN HEPATOCELLULAR CARCINOMA

A New Tool for Intraductal Bile Duct Tissue Sampling: Ex-vivo Clinical Evaluation of Cholangioscopy-guided Cryobiopsy Technique

Lukas Wirsing, Walter Linzenbold, Phillip Stahl, Jan Peveling-Oberhag, Tobias Leibold, Markus Enderle, Joerg Albert

A NEW TOOL FOR INTRADUCTAL BILE DUCT TISSUE SAMPLING: EX-VIVO CLINICAL EVALUATION OF CHOLANGIOSCOPY-GUIDED CRYOBIOPSY TECHNIQUE

Adherence to treatment and therapeutic success in people who inject drugs with hepatis C virus infection in a tertiary care Hepatology Center

Simona Bota, Marcel Razpotnik, Florian Hucke, Kerstin Flatscher, Markus Peck-Radosavljevic

ADHERENCE TO TREATMENT AND THERAPEUTIC SUCCESS IN PEOPLE WHO INJECT DRUGS WITH HEPATIS C VIRUS INFECTION IN A TERTIARY CARE HEPATOLOGY CENTER

ANTICOAGULANT TREATMENT FOR CIRRHOTIC NON-MALIGN PORTAL VEIN THROMBOSIS -EFFICACY AND SAFETY

Irina Girleanu, Anca-Victorita Trifan, Andreea Teodorescu, Camelia Cojocariu, Ana Maria Singeap, Stoica Oana Cristina, Laura Huiban, Carol Stanciu

Anticoagulation and long term prognosis in patients with cirrhosis and portal vein thrombosis

Madalina Greere, Maria Speranta Iacob, Carmen-Cristina Ester, Corina Pietrareanu, Liliana Simona Gheorghe

ASSESSMENT OF NONALCOHOLIC FATTY LIVER DISEASE USING SERUM TOTAL CELL DEATH AND APOPTOSIS MARKERS - COMPARISON WITH THE LIVER BIOPSY

Ivana Mikolasevic, Viktor Domislovic, Zeljko Krznaric, Ivan Jakopcic, Bozena Delija, Nadija Skenderević, Ana Mijic, Tajana Stevanovic, Mia Klapan, Merica Aralica, Lidija Bilic-Zulle, SANDRA MILIC, Davor Stimac, Tajana Filipec Kanizaj

Assessment of the prognostic impact of kidney failure estimated by the Royal Free Hospital Cirrhosis Glomerular Filtration Rate (RFHCGFR) in case of viral cirrhosis C

Nouha Trad, Dhilel Issaoui, Hela Kchir, Soua Sabrine, Yosra Said, Hajer Ben Hassine, Hatem Chaabouni, Nadia Maamouri

Baveno criteria safely identify patients who can avoid variceal screening endoscopy: A diagnostic test accuracy meta-analysis

Zsolt Szakács, Balint Eross, Péter Mátrai, Imre Szabó, Erika Pétervári, Judit Bajor, Nelli Farkas, Peter Hegyi, Anita Illés, Margit Solymár, Márta Balaskó, Patrícia Sarlós, Alexandra Soós, Ákos Szűcs, József Czimmer, Aron Vincze, Gabriella Par

BAVENO CRITERIA SAFELY IDENTIFY PATIENTS WHO CAN AVOID VARICEAL SCREENING ENDOSCOPY: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS

Better management of sorafenib related adverse events impacts on reasons leading to discontinuation and survival

Francesco Tovoli, Luca Ielasi, Francesca Benevento, Fabio Piscaglia

BETTER MANAGEMENT OF SORAFENIB RELATED ADVERSE EVENTS IMPACTS ON REASONS LEADING TO DISCONTINUATION AND SURVIVAL

Blunting of adrenergic function has aquaretic effects In experimental ascitic cirrhosis

Giovanni Sansoe', Manuela Aragno, Nicola Leone, Mohammed Ayoubi, Luciana Framarin, Francesca Castellino

C<sub>60</sub> fullerene: antifibrotic, antitumor and antimetastatic nanotherapeutic for hepatocellular carcinoma treatment

Halyna Kuznietsova, Natalia Dziubenko, Tetiana Herheliuk, Vasyl Hurmach, Oksana Lynchak, Yuriy Prylutskyy, Uwe Ritter

C60 FULLERENE: ANTIFIBROTIC, ANTITUMOR AND ANTIMETASTATIC NANOTHERAPEUTIC FOR HEPATOCELLULAR CARCINOMA TREATMENT

Halyna Kuznietsova

CHANGES IN PLASMA CIRCULATING MICROVESICLES IN PATIENTS WITH HCV-RELATED CIRRHOSIS AFTER TREATMENT WITH DIRECT-ACTING ANTIVIRALS

Changes in plasma circulating microvesicles in patients with HCV-related cirrhosis after treatment with direct-acting antivirals

Alberto Zanetto, Elena Campello, Claudia M. Radu, Cristina Bulato, Sarah Shalaby, Luca Spiezia, Enrica Franceschet, Patrizia Burra, Paolo Simioni, Francesco Paolo Russo

Characteristics and outcome of autoimmune hepatitis-primary biliary cholangitis and autoimmune hepatitis-primary sclerosing cholangitis overlap patients compared to autoimmune hepatitis patients

Maaike Biewenga, A.P. van der Berg, Henk R. van Buuren, A.J.P. van der Meer, C. M.J. Van Nieuwkerk, Wouter De Vos Tot Nederveen Cappel, Johannes Brouwer, Joost P.H. Drenth, Bart van Hoek

CHARACTERISTICS AND OUTCOME OF AUTOIMMUNE HEPATITIS-PRIMARY BILIARY CHOLANGITIS AND AUTOIMMUNE HEPATITIS-PRIMARY SCLEROSING CHOLANGITIS OVERLAP PATIENTS COMPARED TO AUTOIMMUNE HEPATITIS PATIENTS

Maaike Biewenga

CIRRHOSIS ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS UNDERGOING BARIATRIC SURGERY

Paul Thomas Kröner

Cirrhosis Associated with Worse Outcomes in Patients Undergoing Bariatric Surgery

Paul Thomas Kröner, Karn Wijarnpreecha, Saane Hoogenboom, Burcin Taner, Kristopher Croome, Denise Harnois, S. Pungpapong

Clinical overlap of hepatobiliary and rheumatologic pathology: a retrospective study of pravalence

Miguel Saraiva, Emanuel Dias, Guilherme Macedo

CLINICAL OVERLAP OF HEPATOBILIARY AND RHEUMATOLOGIC PATHOLOGY: A RETROSPECTIVE STUDY OF PRAVALENCE

DAPS Score: Predictive Model for Significant fibrosis in IDAHS

Sridhar Sundaram, Harish Darak, Shobna Bhatia

DAPS SCORE: PREDICTIVE MODEL FOR SIGNIFICANT FIBROSIS IN IDAHS

Sridhar Sundaram

Development of a scoring system that outmatch other specific scores in transarterial chemoembolization for hepatocellular carcinoma

Joel Silva, Eduardo Rodrigues-Pinto, Pedro Costa-Moreira, Emanuel Dias, Hélder Cardoso, Pedro Reis Pereira, Susana Lopes, Margarida Marques, Rodrigo Liberal, Rosa Coelho, Ana Patrícia Andrade, Guilherme Macedo

DO HLA-DP/DQ POLYMORPHISMS AND/OR SERUM IP-10 AFFECT RESPONSE TO DIRECT ANTIVIRAL DRUGS THERAPY AMONG HEPATITIS C EGYPTIAN PATIENTS?

Do HLA-DP/DQ polymorphisms and/or serum IP-10 affect response to direct antiviral drugs therapy among hepatitis C Egyptian patients?

Tamer Hydara, Amany Ghazy

Do non-invasive markers of fibrosis have a place in the evaluation of fibrosis in overlap syndrome?

Nour Elleuch, manel moalla, Aya Hammami, hassine amira, Aida Ben Slama, Hanen Jaziri, Ahlem Braham Ep Krifa, Salem Ajmi, Mehdi Ksiaa, Ali Jmaa

DO NON-INVASIVE MARKERS OF FIBROSIS HAVE A PLACE IN THE EVALUATION OF FIBROSIS IN OVERLAP SYNDROME?

Effect of Metformin on IGF-R-induced apoptosis and proliferation in liver cancer cells

Jang Han Jung, Jin Lee

EFFECT OF METFORMIN ON IGF-R-INDUCED APOPTOSIS AND PROLIFERATION IN LIVER CANCER CELLS

EPIDEMIOLOGICAL PROFILE OF CIRRHOTIC PATIENTS WITH DIGESTIVE HEMORRHAGE

Uriah Martelli Glaza

EPIDEMIOLOGICAL PROFILE OF CIRRHOTIC PATIENTS WITH DIGESTIVE HEMORRHAGE

Uriah Martelli Glaza, Julia Goginski, Bruno Rodrigues da Silva, Carlos Roberto Naufel Junior, Renato Nisihara, Adriana Pires Smaniotto, Diego Ribeiro Girardello, Marina Braghini, Kelre Wannlen Campos Silva Araujo, Indrig Beatriz Schetz Zawierucha, Igor Luna Peixoto, Carla Renata Zacachuka, Amanda Correia

ESTABLISHMENT OF A NOVEL DIETARY-INDUCED MOUSE MODEL SHOWING STEATOHEPATITIS WITH SEVERE FIBROSIS

Mayuko Ichimura

Establishment of a novel dietary-induced mouse model showing steatohepatitis with severe fibrosis

Mayuko Ichimura, Hirohisa Ogawa, Minoru Matsumoto, Koichi Tsuneyama

EVIDENCE-BASED PROTOCOL FOR DIAGNOSIS AND TREATMENT IS INDEPENDENTLY ASSOCIATED WITH LOWER MORTALITY IN PATIENTS WITH HEPATORENAL SYNDROME

Jonathan Soldera

EVIDENCE-BASED PROTOCOL FOR DIAGNOSIS AND TREATMENT IS INDEPENDENTLY ASSOCIATED WITH LOWER MORTALITY IN PATIENTS WITH HEPATORENAL SYNDROME

Jonathan Soldera, Alana Z. Terres, Rafael S. Balbinot, Ana L. F. Muscope, Juline I. Balensiefer, Morgana L. Mongen, Bruna Schena, Gilberto L. Rost Jr., Raul A. Balbinot, Silvana Sartori, Louise Zanotto Eberhardt

Exome-wide sequencing study of Primary Sclerosing Cholangitis - a two population study

Jukka Koskela, Michiel Voskuil, Manuel A Rivas, Brandon Avila, Christine Stevens, Samuli Ripatti, Ramnik J. Xavier, Ashwin N. Ananthakrishnan, Harry Sokol, Rinse K. Weersma, Mark J. Daly, Martti A. Färkkila

FACTORS ASSOCIATED WITH AN INCREASE OF LIVER STIFFNESS VALUES IN PATIENTS WITH HCV HEPATITIS WITH SUSTAINED VIROLOGIC RESPONSE

Roxana Lucia Denisa Sirli

Factors associated with an increase of liver stiffness values in patients with HCV hepatitis with sustained virologic response

Roxana Lucia Denisa Sirli, Raluca Lupusoru, Alin Lazar, Apetrei Cristina Florina, Alina Popescu, MIRELA DANILA, Ioan Sporea

Fifteen Years of Hepatocellular Carcinoma, a paradigm shift from Infectious to non-infectious etiology

John Alfredo Raphael Pangilinan, Diana Alcantara-Payawal

FIFTEEN YEARS OF HEPATOCELLULAR CARCINOMA, A PARADIGM SHIFT FROM INFECTIOUS TO NON-INFECTIOUS ETIOLOGY

FREQUENCY OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C PATIENTS TREATED WITH DIRECTLY ACTING ANTIVIRAL AGENTS

Ubedullah bughio, Rehmatullah Bhatti, Adil Hassan, Muhammad Sadik Memon, Saadat Ali Jiskani, Jawaid Iqbal, Soomro Abdul Hafeez, MUHAMMAD AAMIR, Falak Naz, Bushra Kadir, Sana sheikh, Mohsin Ali, Mashooque Ali, Sidra Dars

FUNCTIONAL LIVER RESERVE - A PREDICTIVE FACTOR FOR PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS- A SINGLE CENTER EXPERIENCE

Stoica Oana Cristina

FUNCTIONAL LIVER RESERVE - A PREDICTIVE FACTOR FOR PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS- A SINGLE CENTER EXPERIENCE

Laura Huiban, Carol Stanciu, Cristina Muzica, Ana Maria Singeap, Irina Girleanu, Oana Petrea, Tudor Cuciureanu, Stefan Chiriac, Anca-Victorita Trifan

Gender bias in polycystic liver disease: estradiol stimulates proliferation and influences estrogen receptor expression in PRKCSH knockout cholangiocytes

Lucas H.P. Bernts, Ko van Bakel, Anil Sahin, René H.M. te Morsche, Joost P.H. Drenth

Glecaprevir/pibrentasvir for chronic hepatitis C in large real world experience study

Robert Flisiak, Dorota Zarębska-Michaluk, Ewa Janczewska, Rafał Krygier, Krzysztof Tomasiewicz, Anna Piekarska

Item 1 - 50 / 135

1

2 3